XTX Topco’s 10x Genomics TXG Stock Holding History

XTX Topco’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.55M	Buy	+66,628	New	+$1.75M	0.03%	877
2025 Q4	–	Sell	-81,070	Closed	-$948K	–	3817
2025 Q3	$948K	Buy	81,070 +23,555	+41%	+$307K	0.05%	615
2025 Q2	$666K	Buy	57,515 +9,596	+20%	+$87.5K	0.03%	912
2025 Q1	$418K	Sell	47,919 -4,869	-9%	-$61.4K	0.02%	1155
2024 Q4	$758K	Buy	52,788 +7,780	+17%	+$123K	0.06%	457
2024 Q3	$1.02M	Buy	45,008 +31,844	+242%	+$658K	0.07%	419
2024 Q2	$256K	Sell	13,164 -9,185	-41%	-$241K	0.02%	1065
2024 Q1	$839K	Buy	+22,349	New	+$982K	0.11%	224
2023 Q4	–	Sell	-19,294	Closed	-$796K	–	2169
2023 Q3	$796K	Buy	19,294 +14,233	+281%	+$740K	0.14%	177
2023 Q2	$283K	Buy	+5,061	New	+$274K	0.05%	761
2022 Q1	–	Sell	-1,378	Closed	-$205K	–	959
2021 Q4	$205K	Buy	+1,378	New	+$211K	0.12%	370
2021 Q3	–	Sell	-1,462	Closed	-$286K	–	1071
2021 Q2	$286K	Buy	+1,462	New	+$265K	0.1%	385

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's TXG Position: Q2 2026 in Review

XTX Topco opened a new position in 10x Genomics (TXG) in Q2 2026: 66,628 shares worth $2.55M. The stake represents 0.03% of the portfolio and ranks #877 among its holdings. This is a return to the name: XTX Topco previously reported a position in TXG as recently as Q3 2025.

XTX Topco first reported a position in TXG in Q2 2021 and has held it in 12 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

XTX Topco held 66,628 shares of 10x Genomics worth $2.55M as of Q2 2026.
10x Genomics was a new XTX Topco position in Q2 2026.
10x Genomics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #877 holding.
XTX Topco first reported a position in 10x Genomics in Q2 2021 and has held it in 12 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.